Combining or pooling individual samples when carrying out transcript profiling using microarrays is a fairly common means to reduce both the cost and complexity of data analysis.
Introduction
Microarray technology has enabled the measurement of mRNA abundance on a genomic scale, providing deeper insight into cellular physiology. Microarrays have been applied to many types of biological inquiry such as studying response to environmental changes (15), classification of tumors (37), classification of compound therapeutic mechanism (6) , and prediction of cancer prognosis to name only a few. In toxicology, there has been substantial effort in applying microarray technology as a tool to identify biomarkers (35), develop surrogate toxicity assays (22), determine mechanism (42) and predict toxicity (18) . There have been a number of reviews covering the application of microarray technology to toxicology more extensively (26, 34) .
Despite demonstrated utility, there are many challenges in using microarrays. Among them is the task of extracting useful biological information from the enormous amount of data generated. This challenge has been aided by the development of many new tools over the last few years that facilitate data reduction, visualization and analysis (13, 49) . Another prominent, yet largely unaddressed challenge, is that appropriately powered experimental designs using microarrays can be costly and time consuming (52). This cost has led many scientists to the practice of pooling replicate biological samples, which not only decreases the number of microarrays needed, but also reduces sample preparation for a given study. However, with the practice of pooling comes a loss of opportunity to apply statistical analysis methods that enable the measurement of individual animal variation within the experiment. Furthermore, the ability to correlate individual transcript expression changes back to individual animal phenotypes, which often vary within treatment groups, is lost. This correlation is critical for identification of biomarkers and modeling response. Ultimately the effect of pooling samples as opposed to a statistical analysis of individual samples relates to the balancing of costs versus a tolerance for lack of statistical confidence in the data.
Literature on the topic of pooling samples for microarray experiments tend to be technical reports of formulas for calculating the number of biological samples (pooled or individual) needed for a properly powered analysis (23, 24, 28, 32, 44) . However, this study examines the impact of pooling samples from both a qualitative or "biological" perspective and a quantitative viewpoint. We used the same single-dose time course toxicology samples and pooled them or processed them individually. Three well characterized prototypical toxicants, CLO, DEHP and VPA were selected based upon: 1) knowledge of their mechanism(s) in the scientific literature, 2) the robust expression response in liver following treatment and, 3) their relative effect upon PPAR receptors (3, 16, 33, 38, 48) . The analysis methods employed for analyzing data from pooled or individual sample designs were those typical for microarray users when utilizing the respective designs. This analysis allows researchers to make informed decisions as to appropriate experimental design and sample processing based on their needs and resource constraints.
Materials and Methods
Experimental: Male SD rats (n=5) were given a single dose of test article p.o. and sacrificed 48 and 168 hours post exposure as previously described (29) . Additional groups of animals were sacrificed at 4 and 24 hours (n=3) after exposure see supplemental materials. Doses were selected based upon what was needed to obtain acute hepatotoxicity as determined by range finding studies (data not shown). Clofibrate was dosed at 1000 mg/kg using 0.9% w/v saline as a vehicle (10 ml/kg). DEHP was dosed at 20 g/kg (20ml/kg) and Valproic acid at 2000 mg/kg (10ml/kg) using distilled water as a vehicle. One animal in the VPA group died prior to sacrifice.
Animals were sacrificed and toxicity was evaluated by clinical chemistry, measuring liver weights and histological examination of the liver after staining with H&E.
RNA isolation and Microarray analysis:
Total RNA from liver was isolated with RNA STAT-60 (Tel-Test inc.) according to the manufacturer's protocol. For the POOLED samples, equal amounts of total RNA from each sample within a given treatment group were combined. 10µg of total RNA was labeled and hybridized to Affymetrix RG_U34A arrays according to the Affymetrix protocol (1). Affymetrix fluidics station 400 and Agilent GeneArray scanner 3000 were used. Each sample was hybridized to a single microarray.
Sample Quality: All samples were assessed for RNA quality such as microarray scaling factors, background levels, percent present calls and β-Actin and GAPDH 3'/5' ratios etc.
Samples with high 3'/5' ratios would usually be excluded from further analysis, however, the CLO samples were pooled before the results for the individual animal microarrays were completed. For the remaining two compounds, samples were pooled after the quality of the individual samples was assessed, thus ensuring that the pools for VPA and DEHP contained only high quality samples. This design allowed us to compare the two analysis methods as a worst-case scenario (CLO, with 7 of 26 samples being of suspect quality RNA), and a best-case scenario (VPA and DEHP, where all of the samples are high quality). The data discussed in this publication have been deposited in NCBIs Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are accessible through GEO Series accession number GSE 2303.
Data analysis of INDIVIDUAL samples: Signal intensities were generated from Microarray Suite version 5.0 (MAS5) using the default settings, and a global scaling set to 1500. To apply statistical analysis to the experiment, the fold-change was calculated as the ratio of the two group means based on the observed signal values from MAS5 for the two treatment groups.
To test whether a gene is differentially expressed, an ANOVA model was fitted on each of the 8799 probe sets on the chip. The intensity value, Affymetrix MAS5 signal, of a particular gene was modeled as Where Y ki is the signal of animal i from treatment group k, k µ is the group mean of treatment k, and ki ε is the measurement error (combination of sample variation and chip-to-chip variation)
Since thousands of hypotheses were tested simultaneously, the issue of multiplicity is a concern. To estimate the false positives, Benjamini and Hochberg's (Benjamini and Hochberg, 1995 
Results
The transcriptional response to the toxicants was dynamic over the time course ( QRTPCR analysis of transcript changes falling in the various regions of the Venn diagram, generated from the data set, highlights additional differences between the approaches.
Five or six transcripts from each of the three regions of the Venn diagram representing unique and overlapping areas of the VPA data set ( Figure 2C ) were arbitrarily chosen for technical confirmation by QRTPCR of the VPA samples. The results from the QRTPCR analysis are shown in Table 1 . It is striking to note that none of the transcripts unique to the VPA POOLED analysis were confirmed as being statistically significant (p-value ≤0.05) when the individual samples were evaluated by QRTPCR, suggesting a high false positive rate for this subset of transcripts upon pooling. The changes for both the overlap and the transcripts detected uniquely in the individual samples were confirmed by QRTPCR as being statistically significant changes.
Therefore, all changes identified by the statistical microarray analysis and tested by QRTPCR were confirmed. Among these transcripts, the INDIVIDUAL analysis identified three transcripts (sodium channel β-1, selenoprotein W, and lanosterol 14-demethylase) called "not changed" by the MAS5 algorithm and therefore missed by the POOLED approach. Each of these transcripts were strongly regulated (5.7, 2.3, and -5.3 fold, respectively), detected by the individual analysis and were significantly regulated when checked by QRTPCR.
To determine the impact of a POOLED versus INDIVIDUAL analysis on sample classification, all 48 hour array data was analyzed using principal component analysis (PCA) and hierarchical clustering (HCS), as shown in Figure 3A . Treatment with the three toxicants separated from the vehicle along the first and second principal components while differences between compounds separated along the third principal component. A clear compound dependent effect relative to vehicle control was observed using PCA. As expected, the pooled samples for each compound consistently clustered tightly with the individual samples from their respective groups in the PCA.
The VPA and DEHP samples clustered more closely together than with CLO. In addition, the spread between the individual animals in the CLO group was larger in magnitude than observed for the other compounds. CLO samples that were distanced from the center of the clusters in PCA were lower quality samples. Three of the five vehicle-treated animals (methylcellulose in the CLO study) had 3'/5' β-actin ratios of greater than3, and two of five CLO-treated animals had ratios of greater than3 indicating that the RNA was partially degraded before labeling the samples. While these parameters were outside of normal ranges, other QC parameters for these samples were within normal limits. All other CLO samples including Minimal changes in pathology were observed in these studies and all changes were reversed by 168 hours after treatment. Some vacuolation, hypertrophy and increases in mitotic figures were noted, however the most dramatic response to the compounds was an increase in absolute liver weight noted at 24 and 48 hours. An advantage of the INDIVIDUAL approach is the opportunity to correlate the transcript profiles to the phenotype, sometimes called "phenotypic anchoring". For example, a subtle increase in liver weight was observed in the CLO treated animals at 48 hours. Spearman's's correlation was used to identify specific transcripts that correlate with increased liver weight (Figure 4 A, The POOLED and INDIVIDUAL data from each compound were also mapped to metabolic pathways using GenMapp (11, 12) in order to compare pathways identified by each analytical approach. The mitochondrial long chain fatty acid beta-oxidation pathway is illustrated in Figure   5 for VPA (figures for all three compounds can be found in the supplemental materials). As might be expected, all three compounds modulated multiple transcripts that code for components of the beta-oxidation pathway ( Table 2 ). The INDIVIDUAL analysis identified more components of the pathway than did the POOLED analysis yet both approaches identified this pathway as having more of its genes modulated than would be expected by random chance. (23, 24, 32) . In sub-pooling, multiple animals from within a treatment group are pooled into multiple, evenly distributed sub-groups, thus reducing the variability as well as the number of microarrays that are processed. Two of these papers are based primarily on an in-silico analysis and each suggest that in order to achieve the same level of precision, sub-pooling requires substantially more biological samples than is needed for individual samples. This is not cost effective for many in vivo experiments. Although these studies have examined the pros and cons of both designs to some degree, none has directly compared the expression changes observed using typical analytical methods commonly associated each design.
The rationale for pooling samples tends to be non-technical (limited sample RNA) and generally involves savings in time and reagent costs. In our experience time and cost can be reduced up to five fold by pooling samples. The benefits of an individual animal approach are many and include: 1) estimation of biological variation, 2) robust statistical testing as opposed to heuristic filtering and, 3) association with phenotypic data when available 4) more information to apply to mechanistic analysis. Statistics provide a quantitative measure of the probability of false positives in the data based upon signal relative to noise and observed sample variation.
Therefore, statistical measures of confidence, such as FDR, provide a mechanism for rational data filtering that incorporates knowledge of false positive rates. In our comparison of POOLED and INDIVIDUAL design, changes unique to the POOLED analysis did not validate when evaluated with QRTPCR (n=5) using individual sample RNA, indicating that they are likely to be false positives ( Table 1) . This loss in confirmation of transcripts by QRTPCR was a result of large variation in signal between samples within the treatment group as opposed to a technical problem related to the probe sets representing these transcripts on the microarray. This is supported by the observation that we could confirm the unique to pooled changes by QRTPCR using pooled sample RNA (data not shown). The changes identified from the pooled data set that failed to validate can impact the interpretation of the data as demonstrated by the fact that at 168 hours post-dosing, CLO still regulated a number of changes (supplemental materials) in the pooled samples, but none of these changes were statistically significant.
The expression changes uniquely identified by the individual analysis enhanced biological interpretation of the experiment. Three regulated transcripts identified in the INDIVIDUAL analysis were sodium channel β-1, selenoprotein W, and lanosterol 14-demethylase that were called "not changed" by MAS5 and therefore not called changed in the POOLED approach. These transcripts were strongly regulated (> 5-fold) and were confirmed by QRTPCR (with primers designed independently of the probe sequences on the arrays) Each of the three transcripts had a high level of hybridization to the Affymetrix mismatch probes, providing an explanation for why MAS5 did not pick up the change. Interestingly, VPA has been shown to modulate sodium channel β-1 and this is likely associated with its pharmacological mechanism of action (51). The increase in lanosterol-14-demethylase transcript after VPA treatment has not been reported previously. This enzyme is involved in cholesterol biosynthesis and trafficking of sterols. Down regulation of this transcript and the cholesterol esterase ( (Figures 1 and 2) , a result similar to those reported by others (14).
While most of the transcript changes detected by the INDIVIDUAL design had fold-changes less than two, 20% of these changes were greater than two (Figure 2) . The identification of additional differentially expressed transcripts, even if subtle, increases the sensitivity in identifying modulated pathways that can impact biological interpretation of data. Here, gene expression changes were mapped to the fatty acid beta-oxidation pathway, a pathway that all of these compounds are known to affect via their interaction with the PPAR alpha receptor (54). It was clear from this exercise that the POOLED versus INDIVIDUAL analysis gave the same result from a high level view; i.e. expected effects on fatty acid oxidation were evident for both approaches.
Still some important differences were evident using this comparative analysis. For example, the Subtle changes in transcript abundance identified by statistical analysis may also be biologically interesting since a number of laboratories have demonstrated discordance between mRNA and protein levels (5, 10, 17, 19, 45) . Subtle changes in mRNA abundance may relate to a dramatic impact on protein activity that may be missed without the sensitivity enabled by In summary, while the two approaches to running microarray chips were comparable, pooling saves considerable time and resources at the expense of statistical confidence in the data.
The ability to correlate expression data to other datasets and phenotypes can be critical for effective modeling, the building of training sets or biomarker discovery (7, 30). As has been done with the classification of cancers, the analysis of individual samples is required to provide appropriate power for predictive modeling (4, 40, 46, 47) . This is an important issue in toxicology since microarrays have been heralded for their potential use in building a predictive database of prototypical toxicants (26, 43). As we have seen, the INDIVIDUAL analysis revealed subtle changes that affect interpretation of the experiment that was lost in the POOLED analysis and important for mechanistic understanding. Although there are dissenting opinions as to the value of pooled or individual experimental designs, an INDIVIDUAL approach becomes more valuable where the variation in phenotypic response is large and/or the overall response is subtle.
A POOLED approach is better employed where the expected response or phenotype is robust and its variation in that response is minimal.
Supplemental Materials
The supplemental materials contain five files that are available for downloading. An experimental design summary table is provided, DesignTable.doc. The raw microarray data for this manuscript is contained in the file, "Fold-change data.zip". This file contains the complete statistical analysis of the INDIVIDUAL data for all probe sets with a P-value below 0.05, as well as the MAS5 output for the POOLED samples. A more detailed protocol for the QRTPCR analysis is included in the file, "Detailed QRTPCR protocol.doc"; the primers that were used for these reactions can be found in the file, "QRTPCR primer sequences.xls". Additional figures for Figure 2 of the VPA 48 hr samples for technical confirmation. This table compares the microarray data for these probe sets for both approaches as well as the QRTPCR results when samples were run individually and pooled together. Table 2 . Impact of approaches on compound-related effects assessed by pathway analysis. The 48 hr array data for three compounds were applied to GenMapp pathways using the MappFinder tool. Pathways listed had a positive z-score for at least one treatment and analysis, and a minimum of five transcripts per pathway needed to be changed for a given pathway to be listed.
The shaded values reflect a z-score below zero, indicating that for that treatment, the pathway is under-represented. 
